At Enobia, we recognize the challenges of living with HPP. We are focused on developing ENB-0040, an investigational enzyme replacement therapy, which we hope will provide a new treatment option for patients with HPP.
ENB-0040 is currently in Phase 2 clinical development and is not yet approved by regulatory authorities.
"What is Hypophosphatasia?" Cartoon by BrainPOP
BrainPOP (www.brainpop.com) creates animated, curriculum-based content that engages students, supports teachers, and bolsters achievement. Its award-winning resources include BrainPOP Jr. (K-3), BrainPOP (grades 3-8), BrainPOP Español, and BrainPOP ESL. BrainPOP sites host more than 7 million visits each month. Visit BrainPOP at www.brainpop.com